Literature DB >> 9799484

The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells.

M Morishima-Kawashima1, Y Ihara.   

Abstract

To investigate the intracellular compartmentalization of amyloid beta-protein (Abeta), human neuroblastoma SH-SY5Y cells were fractionated and the Abeta content in each fraction was quantitated by the well-characterized two-site enzyme-linked immunosorbent assay (ELISA). Subcellular fractionation of the cell revealed two distinct pools of Abeta within the cells: a Triton-soluble and a Triton-insoluble pools with the latter being larger than the former. Because Triton insolubility points to caveolae-like domains, we prepared detergent-insoluble, low-density membrane domains from SH-SY5Y cells using two different protocols. The low-density membrane fraction prepared by either protocol was found to contain a substantial proportion of intracellular Abeta40 and Abeta42. These results indicate that the distinct membrane domains are involved in the generation and/or trafficking of Abeta.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799484     DOI: 10.1021/bi981843u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization.

Authors:  Rui-Qin Liu; Qing-Hua Zhou; Shang-Rong Ji; Qiang Zhou; Du Feng; Yi Wu; Sen-Fang Sui
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

2.  Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors.

Authors:  Alexandra M Nicholson; D Nicole Riherd Methner; Adriana Ferreira
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

3.  Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

Authors:  Dominic M Walsh; Matthew Townsend; Marcia B Podlisny; Ganesh M Shankar; Julia V Fadeeva; Omar El Agnaf; Dean M Hartley; Dennis J Selkoe
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 4.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 5.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

6.  Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life.

Authors:  Ganesh M Shankar; Malcolm A Leissring; Anthony Adame; Xiaoyan Sun; Edward Spooner; Eliezer Masliah; Dennis J Selkoe; Cynthia A Lemere; Dominic M Walsh
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

Review 7.  Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases.

Authors:  G Brent Irvine; Omar M El-Agnaf; Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

8.  CHOLESTEROL AND NEURONAL SUSCEPTIBILITY TO BETA-AMYLOID TOXICITY.

Authors:  Alexandra M Nicholson; Adriana Ferreira
Journal:  Cogn Sci (Hauppauge)       Date:  2010-07-01

9.  Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains.

Authors:  Maho Morishima-Kawashima; Xianlin Han; Yu Tanimura; Hiroki Hamanaka; Mariko Kobayashi; Takashi Sakurai; Minesuke Yokoyama; Koji Wada; Nobuyuki Nukina; Shinobu C Fujita; Yasuo Ihara
Journal:  J Neurochem       Date:  2007-05       Impact factor: 5.372

10.  Alzheimer's disease: synaptic dysfunction and Abeta.

Authors:  Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Neurodegener       Date:  2009-11-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.